SVB WEALTH LLC - TCR2 THERAPEUTICS INC ownership

Quarter-by-quarter ownership
SVB WEALTH LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$358,000
-74.1%
42,084
-50.0%
0.01%
-72.2%
Q2 2021$1,381,000
-13.8%
84,167
+16.0%
0.02%
-18.2%
Q1 2021$1,602,000
-28.6%
72,5340.0%0.02%
-33.3%
Q4 2020$2,243,000
+34.8%
72,534
-11.4%
0.03%
+22.2%
Q3 2020$1,664,000
+32.3%
81,9090.0%0.03%
+17.4%
Q2 2020$1,258,000
+231.9%
81,909
+67.2%
0.02%
+155.6%
Q1 2020$379,000
-45.8%
48,9750.0%0.01%
-30.8%
Q4 2019$699,00048,9750.01%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders